Junya Furukawa

1.8k total citations
119 papers, 1.3k citations indexed

About

Junya Furukawa is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Junya Furukawa has authored 119 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pulmonary and Respiratory Medicine, 46 papers in Surgery and 37 papers in Oncology. Recurrent topics in Junya Furukawa's work include Renal cell carcinoma treatment (46 papers), Bladder and Urothelial Cancer Treatments (32 papers) and Prostate Cancer Treatment and Research (22 papers). Junya Furukawa is often cited by papers focused on Renal cell carcinoma treatment (46 papers), Bladder and Urothelial Cancer Treatments (32 papers) and Prostate Cancer Treatment and Research (22 papers). Junya Furukawa collaborates with scholars based in Japan, Canada and United States. Junya Furukawa's co-authors include Masato Fujisawa, Hideaki Miyake, Tomoaki Terakawa, Mototsugu Muramaki, Nobuyuki Hinata, Atsushi Takenaka, Isao Hara, Kenichi Harada, Yuzo Nakano and Kazushi Tanaka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Junya Furukawa

106 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junya Furukawa Japan 18 602 363 360 335 170 119 1.3k
Wataru Obara Japan 19 516 0.9× 402 1.1× 440 1.2× 452 1.3× 207 1.2× 139 1.2k
Yoshihiro Tatsumi Japan 19 277 0.5× 483 1.3× 368 1.0× 374 1.1× 177 1.0× 60 1.2k
Noriyuki Ito Japan 22 293 0.5× 274 0.8× 392 1.1× 281 0.8× 73 0.4× 95 1.1k
Kristen Lecksell United States 17 338 0.6× 307 0.8× 185 0.5× 306 0.9× 131 0.8× 22 964
Minyong Kang South Korea 23 684 1.1× 583 1.6× 513 1.4× 475 1.4× 112 0.7× 156 1.8k
Qun He China 24 536 0.9× 518 1.4× 388 1.1× 268 0.8× 75 0.4× 120 1.5k
Mikio Sugimoto Japan 19 804 1.3× 335 0.9× 325 0.9× 388 1.2× 38 0.2× 148 1.4k
Alexander H. Boag Canada 16 505 0.8× 179 0.5× 710 2.0× 375 1.1× 63 0.4× 40 1.5k
Maria Matsangou United States 16 419 0.7× 703 1.9× 631 1.8× 804 2.4× 157 0.9× 42 1.8k
Yacine Salhi United States 15 485 0.8× 936 2.6× 163 0.5× 769 2.3× 95 0.6× 32 1.7k

Countries citing papers authored by Junya Furukawa

Since Specialization
Citations

This map shows the geographic impact of Junya Furukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junya Furukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junya Furukawa more than expected).

Fields of papers citing papers by Junya Furukawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junya Furukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junya Furukawa. The network helps show where Junya Furukawa may publish in the future.

Co-authorship network of co-authors of Junya Furukawa

This figure shows the co-authorship network connecting the top 25 collaborators of Junya Furukawa. A scholar is included among the top collaborators of Junya Furukawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junya Furukawa. Junya Furukawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Blas, Leandro, Masaki Shiota, Takuma Kato, et al.. (2025). Active Surveillance in Prostate Cancer With Intermediate‐Risk Features: The PRIAS‐JAPAN Study. International Journal of Urology. 32(7). 823–827. 2 indexed citations
4.
Katayama, Satoshi, Yoichiro Tohi, Keita Kobayashi, et al.. (2025). Needlestick Injury During Urological Surgery: A 15‐Year Review From a Multi‐Institutional Study in the Chugoku–Shikoku Japan Urological Consortium. International Journal of Urology. 32(12). 1873–1877.
5.
Daizumoto, Kei, Takeshi Nakashima, Tomoya Fukawa, et al.. (2025). Prognostic Significance of Achieving the Radical Cystectomy‐Pentafecta After Neoadjuvant Chemotherapy and Robot‐Assisted Radical Cystectomy. International Journal of Urology. 33(1). e70283–e70283.
6.
Daizumoto, Kei, Yoshito Kusuhara, Kunihisa Yamaguchi, et al.. (2025). Use of the Assistent Guide Facilitates Ureteral Stent Placement in Robot‐Assisted Pyeloplasty. Asian Journal of Endoscopic Surgery. 18(1). e70178–e70178.
7.
Yamashita, Shimpei, Shuzo Hamamoto, Junya Furukawa, et al.. (2024). Association of lung immune prognostic index with survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab. Japanese Journal of Clinical Oncology. 54(6). 722–729. 2 indexed citations
8.
Kato, Taigo, Junya Furukawa, Nobuyuki Hinata, et al.. (2024). Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study. International Journal of Clinical Oncology. 30(1). 99–109. 2 indexed citations
9.
Hinata, Nobuyuki, Yuzo Nakano, Isao Hara, et al.. (2024). Efficacy of robot-assisted partial nephrectomy compared to conventional laparoscopic partial nephrectomy for completely endophytic renal tumor: a multicenter, prospective study. International Journal of Clinical Oncology. 29(10). 1548–1556. 1 indexed citations
10.
Hamamoto, Shuzo, Shimpei Yamashita, Junya Furukawa, et al.. (2024). External validation of hemoglobin and neutrophil levels as predictors of the effectiveness of ipilimumab plus nivolumab for treating renal cell carcinoma. Frontiers in Oncology. 14. 1400041–1400041.
11.
Daizumoto, Kei, Yoshito Kusuhara, Tomoya Fukawa, et al.. (2024). Retroperitoneal cutaneous ureterostomy following radical cystectomy: A multicenter comparative study of robotic versus open surgery. International Journal of Urology. 31(12). 1408–1413.
12.
13.
Furukawa, Junya, et al.. (2023). Renal cell carcinoma in the contralateral kidney with TFE3 gene translocation following chemotherapy for childhood nephroblastoma: A case report and literature review. SHILAP Revista de lepidopterología. 11(11). e8128–e8128. 1 indexed citations
14.
Hara, Takuto, Junya Furukawa, Tomoaki Terakawa, et al.. (2023). Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma. International Journal of Urology. 30(9). 746–752. 9 indexed citations
15.
Yamamoto, Kazuhiro, Satoshi Ogawa, Junya Furukawa, et al.. (2020). Model-based assessment of pharmacokinetic changes of sunitinib, tacrolimus, and everolimus in a patient with metastatic renal cell carcinoma after renal transplantation. Drug Metabolism and Pharmacokinetics. 35(5). 405–409. 1 indexed citations
16.
Terakawa, Tomoaki, Ahmed A. Hussein, Khurshid A. Guru, et al.. (2018). Presurgical pazopanib for renal cell carcinoma with inferior vena caval thrombus. Anti-Cancer Drugs. 29(6). 565–571. 9 indexed citations
17.
Miyake, Hideaki, Akira Miyazaki, Junya Furukawa, Nobuyuki Hinata, & Masato Fujisawa. (2016). Prospective assessment of time-dependent changes in quality of life of Japanese patients with prostate cancer following robot-assisted radical prostatectomy. Journal of Robotic Surgery. 10(3). 201–207. 17 indexed citations
18.
Furukawa, Junya, et al.. (2016). Oncologic Outcome of Radical Prostatectomy as Monotherapy for Men with High-risk Prostate Cancer. Current Urology. 9(2). 67–72. 5 indexed citations
19.
Kumano, Masafumi, Junya Furukawa, Masaki Shiota, et al.. (2012). Cotargeting Stress-Activated Hsp27 and Autophagy as a Combinatorial Strategy to Amplify Endoplasmic Reticular Stress in Prostate Cancer. Molecular Cancer Therapeutics. 11(8). 1661–1671. 47 indexed citations
20.
Miyake, Hideaki, Junya Furukawa, Iori Sakai, et al.. (2011). Orthotopic sigmoid vs. ileal neobladders in Japanese patients: A comparative assessment of complications, functional outcomes, and quality of life. Urologic Oncology Seminars and Original Investigations. 31(7). 1155–1160. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wataru Obara Breakdown of academic impact, for papers by Yoshihiro Tatsumi Breakdown of academic impact, for papers by Noriyuki Ito Breakdown of academic impact, for papers by Kristen Lecksell Breakdown of academic impact, for papers by Minyong Kang Breakdown of academic impact, for papers by Qun He Breakdown of academic impact, for papers by Mikio Sugimoto Breakdown of academic impact, for papers by Alexander H. Boag Breakdown of academic impact, for papers by Maria Matsangou Breakdown of academic impact, for papers by Yacine Salhi
Rankless by CCL
2026